|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 27.52 USD | +4.52% |
|
-16.17% | -3.68% |
| Capitalization | 2.62B 2.26B 2.07B 1.96B 3.61B 254B 3.7B 24.68B 9.61B 119B 9.83B 9.63B 417B | P/E ratio 2026 * |
-6x | P/E ratio 2027 * | -5.75x |
|---|---|---|---|---|---|
| Enterprise value | 1.77B 1.52B 1.4B 1.32B 2.43B 171B 2.49B 16.63B 6.48B 80.5B 6.63B 6.49B 281B | EV / Sales 2026 * |
24.1x | EV / Sales 2027 * | 15.7x |
| Free-Float |
98.64% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Beam Therapeutics Inc.
| 1 day | +4.58% | ||
| 1 week | -16.17% | ||
| Current month | -11.97% | ||
| 1 month | -14.40% | ||
| 3 months | -3.23% | ||
| 6 months | +29.61% | ||
| Current year | -3.68% |
| 1 week | 25.87 |  | 32.12 |
| 1 month | 25.87 | | 34.38 |
| Current year | 21.63 | | 36.44 |
| 1 year | 15.35 | | 36.44 |
| 3 years | 13.52 | | 49.5 |
| 5 years | 13.52 | | 138.52 |
| 10 years | 13 | | 138.52 |
| Manager | Title | Age | Since |
|---|---|---|---|
John Evans
CEO | Chief Executive Officer | 48 | 31/12/2016 |
Sravan Emany
DFI | Director of Finance/CFO | 48 | 18/12/2024 |
| President | 57 | 23/01/2020 |
| Director | Title | Age | Since |
|---|---|---|---|
John Evans
BRD | Director/Board Member | 48 | 31/12/2016 |
Mark Fishman
BRD | Director/Board Member | 75 | 30/04/2018 |
Graham Cooper
BRD | Director/Board Member | 56 | 09/10/2019 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +4.52% | -16.17% | +50.42% | -24.04% | 2.62B | |
| +0.94% | +2.95% | -13.47% | -15.42% | 43.14B | |
| +3.58% | -3.79% | +28.58% | +25.82% | 33.02B | |
| +3.81% | +0.79% | +273.41% | +466.20% | 31.32B | |
| -3.44% | -4.00% | +14.16% | -17.99% | 28.9B | |
| -0.38% | -5.59% | +23.25% | +14.60% | 25.34B | |
| +0.06% | -2.83% | - | - | 14.78B | |
| +2.57% | -0.51% | +129.75% | +4,203.36% | 13.35B | |
| +1.17% | +5.41% | +8.92% | +2.14% | 12.5B | |
| -2.57% | -4.06% | +32.60% | +94.01% | 11.99B | |
| Average | +1.02% | -1.83% | +60.85% | +527.63% | 21.7B | |
| Weighted average by Cap. | +0.90% | -0.77% | +60.79% | +355.36% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 73.19M 63.12M 57.82M 54.64M 101M 7.09B 103M 689M 268M 3.34B 275M 269M 11.65B | 92.07M 79.41M 72.74M 68.74M 127M 8.91B 130M 867M 338M 4.2B 345M 338M 14.65B |
| Net income | -465M -401M -367M -347M -640M -45B -656M -4.38B -1.7B -21.18B -1.74B -1.71B -73.97B | -518M -447M -409M -387M -713M -50.16B -731M -4.88B -1.9B -23.62B -1.94B -1.9B -82.46B |
| Net Debt | -855M -737M -675M -638M -1.18B -82.73B -1.21B -8.05B -3.13B -38.95B -3.21B -3.14B -136B | -1.17B -1.01B -926M -875M -1.61B -113B -1.65B -11.03B -4.3B -53.41B -4.4B -4.3B -186B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 20/05/26 | 26.73 $ | +1.52% | 203,169 |
| 19/05/26 | 26.33 $ | -1.79% | 1,488,201 |
| 18/05/26 | 26.81 $ | -4.01% | 2,002,872 |
| 15/05/26 | 27.93 $ | -5.42% | 2,010,429 |
| 14/05/26 | 29.53 $ | -7.28% | 2,424,202 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- BEAM Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition